Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121983002 | 12198300 | 2 | F | 2004 | 20160620 | 20160322 | 20160830 | PER | US-JNJFOC-20160307923 | JANSSEN | 0.00 | C | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121983002 | 12198300 | 1 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.25MG-0.50MG | U | U | 0 | TABLETS | |||||||
| 121983002 | 12198300 | 2 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
| 121983002 | 12198300 | 3 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.5MG, 1MG, 3MG | U | U | 0 | TABLETS | |||||||
| 121983002 | 12198300 | 4 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.5MG, 1MG, 3MG | U | U | 0 | TABLETS | |||||||
| 121983002 | 12198300 | 5 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
| 121983002 | 12198300 | 6 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.25MG-0.50MG | U | U | 0 | TABLETS | |||||||
| 121983002 | 12198300 | 7 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.25MG-0.50MG | U | U | 0 | TABLETS | |||||||
| 121983002 | 12198300 | 8 | SS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 0 | 1 | MG | TABLETS | ||||||
| 121983002 | 12198300 | 9 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | 0.5MG, 1MG, 3MG | U | U | 20272 | TABLETS | |||||||
| 121983002 | 12198300 | 10 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLETS |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121983002 | 12198300 | 1 | Anxiety |
| 121983002 | 12198300 | 2 | Anxiety |
| 121983002 | 12198300 | 3 | Anxiety |
| 121983002 | 12198300 | 4 | Attention deficit/hyperactivity disorder |
| 121983002 | 12198300 | 5 | Attention deficit/hyperactivity disorder |
| 121983002 | 12198300 | 6 | Attention deficit/hyperactivity disorder |
| 121983002 | 12198300 | 7 | Depression |
| 121983002 | 12198300 | 8 | Depression |
| 121983002 | 12198300 | 9 | Depression |
| 121983002 | 12198300 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121983002 | 12198300 | Abnormal weight gain | |
| 121983002 | 12198300 | Gynaecomastia | |
| 121983002 | 12198300 | Off label use | |
| 121983002 | 12198300 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121983002 | 12198300 | 1 | 20070512 | 20080620 | 0 | |
| 121983002 | 12198300 | 2 | 2004 | 0 | ||
| 121983002 | 12198300 | 3 | 20090420 | 20120501 | 0 | |
| 121983002 | 12198300 | 4 | 20090420 | 20120501 | 0 | |
| 121983002 | 12198300 | 5 | 2004 | 0 | ||
| 121983002 | 12198300 | 6 | 20070512 | 20080620 | 0 | |
| 121983002 | 12198300 | 7 | 20070512 | 20080620 | 0 | |
| 121983002 | 12198300 | 8 | 2004 | 0 | ||
| 121983002 | 12198300 | 9 | 20090420 | 20120501 | 0 |